Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Clinical Course of Patients with Coronary Ectasia

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective: To compare the clinical prognosis between patients with diffuse coronary ectasia and those with localized coronary ectasia. Design: Patients with coronary ectasia were divided into two groups based on the Markis classification (group D: types I–III and group L: type IV), and the clinical manifestations and prognosis were compared between the two groups. Results: Group D patients (52.1 ± 4 years) were significantly younger than group L patients (62.5 ± 7 years). During the study, 4 patients in group D died suddenly. Three of the patients had type I coronary ectasia, and 1 had left main coronary ectasia. Conclusion: The results of the present study indicate that patients with diffuse coronary ectasia and left main coronary ectasia should be followed carefully.

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: not found
          • Article: not found

          Myocardial infarction and coronary ectasia in idiopathipc mitral valve prolapse syndrome

           S KUmar (1980)
            Bookmark

            Author and article information

            Journal
            CRD
            Cardiology
            10.1159/issn.0008-6312
            Cardiology
            S. Karger AG
            0008-6312
            1421-9751
            1999
            September 1999
            24 September 1999
            : 91
            : 3
            : 145-149
            Affiliations
            First Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
            Article
            6901 Cardiology 1999;91:145–149
            10.1159/000006901
            10516406
            © 1999 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            Page count
            Figures: 3, Tables: 2, References: 23, Pages: 5
            Categories
            General Cardiology

            Comments

            Comment on this article